-
Jan 4, 2024, 10:01 AM
by
User Not Found
Bio-IT World | Spatial biology, large language models, and new informatics tools. Bio-IT is exploring how AI fits into workstreams, still wrangling with data management challenges, and shaping discovery for the new era. Here are the top stories from Bio-IT World as well as thought leaders in the industry.
Full story
-
Jan 4, 2024, 09:01 AM
by
Demonstrates Commitment to Delivering Superior Products and Services to Customers
Full story
-
Jan 3, 2024, 08:52 AM
by
PubHive tackles pharmacovigilance inefficiencies! Centralized SmPC management and AI workflows boost speed, compliance, and patient safety.
Full story
-
Jan 3, 2024, 01:00 AM
by
User Not Found
Bio-IT World | To kick off the New Year, we spoke with leaders and experts in the Bio-IT community about their predictions for 2024.
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Huateng Pharma introduces Tetrahydrocurcumin, a dual-action antioxidant and skin-whitening agent, alongside Pro-xylane and (S)-Pro-xylane, potent anti-ageing agents, and Piroctone Olamine, an effective anti-dandruff solution, emphasizing a commitment to quality and versatility from lab to commercial scale.
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:12 AM
by
Full story
-
Jan 2, 2024, 09:06 AM
by
Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).
Full story
-
Jan 2, 2024, 09:06 AM
by
BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.
Full story